









Markets
/
Stocks
/
nasdaq-arct
/

Arcturus Therapeutics Holdings Inc

ARCT

View Detailed Chart

12.300USD

0.0000.00%

Close 08/01, 16:00（ET）Quotes delayed by 15 min

333.59MMarket Cap

LossP/E TTM



Arcturus Therapeutics Holdings Inc

12.300

0.0000.00%

Overview Company Financials

Financials

Intraday

30m

Today

+0.74%

5 Days

-17.67%

1 Month

-10.74%

6 Months

-22.15%

Year to Date

-27.52%

1 Year

-40.15%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 12 analysts

BUY

Current Rating

59.364

Target Price

382.63%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

552

Total

Median

Average

Company name

Ratings

Analysts

Arcturus Therapeutics Holdings Inc

ARCT

CRISPR Therapeutics AG

CRSP

Intellia Therapeutics Inc

NTLA

Exact Sciences Corp

EXAS

Ionis Pharmaceuticals Inc

IONS

IQVIA Holdings Inc

IQV

...

111

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Sell

Sell(8)

Neutral(2)

Buy(0)

Indicators

Sell(2)

Neutral(2)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.542

Neutral

RSI(14)

40.581

Neutral

STOCH(KDJ)(9,3,3)

10.853

Oversold

ATR(14)

0.880

High Vlolatility

CCI(14)

-125.793

Sell

Williams %R

89.141

Oversold

TRIX(12,20)

0.152

Sell

StochRSI(14)

5.325

Oversold

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

12.924

Sell

MA10

13.828

Sell

MA20

13.742

Sell

MA50

13.151

Sell

MA100

12.430

Sell

MA200

14.980

Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Arcturus Therapeutics Holdings Inc. is a global messenger RNA medicines and vaccine company. The Company is focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. In addition to its messenger RNA (mRNA) platform, its lipid nanoparticle (LNP) delivery system, LUNAR, has the potential to enable multiple nucleic acid medicines, and its self-amplifying mRNA technology (Self-Transcribing and Replicating RNA (STARR), technology) has the potential to provide longer-lasting RNA and sustained protein expression at lower dose level. It is leveraging its LUNAR platform and its nucleic acid technologies to develop and advance a pipeline of mRNA-based vaccines and therapeutics for infectious diseases and rare genetic disorders with significant unmet medical needs. Its COVID-19 vaccine candidate, which is based on its STARR technology platform is through Phase II clinical trials.

Ticker SymbolARCT

CompanyArcturus Therapeutics Holdings Inc

CEOMr. Joseph E. Payne

Websitehttps://arcturusrx.com/